nodes	percent_of_prediction	percent_of_DWPC	metapath
Penicillamine—SLCO1B1—Repaglinide—type 2 diabetes mellitus	0.196	0.256	CbGbCtD
Penicillamine—SLCO1B1—Pioglitazone—type 2 diabetes mellitus	0.177	0.232	CbGbCtD
Penicillamine—SLCO1B1—Rosiglitazone—type 2 diabetes mellitus	0.164	0.214	CbGbCtD
Penicillamine—SLCO1B1—Valsartan—type 2 diabetes mellitus	0.145	0.189	CbGbCtD
Penicillamine—SLCO1B1—Losartan—type 2 diabetes mellitus	0.0831	0.109	CbGbCtD
Penicillamine—L-Cysteine—CDO1—type 2 diabetes mellitus	0.00293	0.608	CrCbGaD
Penicillamine—L-Cysteine—CBS—type 2 diabetes mellitus	0.00189	0.392	CrCbGaD
Penicillamine—SLCO1B1—Codeine and Morphine Metabolism—ABCC2—type 2 diabetes mellitus	0.00183	0.114	CbGpPWpGaD
Penicillamine—SLCO1B1—Codeine and Morphine Metabolism—CYP3A4—type 2 diabetes mellitus	0.0012	0.0745	CbGpPWpGaD
Penicillamine—SLCO1B1—Irinotecan Pathway—ABCC2—type 2 diabetes mellitus	0.00117	0.0726	CbGpPWpGaD
Penicillamine—SLCO1B1—Drug Induction of Bile Acid Pathway—ABCC2—type 2 diabetes mellitus	0.001	0.0622	CbGpPWpGaD
Penicillamine—SLCO1B1—Transport of organic anions—AVP—type 2 diabetes mellitus	0.000778	0.0483	CbGpPWpGaD
Penicillamine—SLCO1B1—Irinotecan Pathway—CYP3A4—type 2 diabetes mellitus	0.000767	0.0476	CbGpPWpGaD
Penicillamine—SLCO1B1—Drug Induction of Bile Acid Pathway—CYP3A4—type 2 diabetes mellitus	0.000657	0.0408	CbGpPWpGaD
Penicillamine—SLCO1B1—Transport of organic anions—ALB—type 2 diabetes mellitus	0.000471	0.0292	CbGpPWpGaD
Penicillamine—SLCO1B1—Recycling of bile acids and salts—ALB—type 2 diabetes mellitus	0.000349	0.0217	CbGpPWpGaD
Penicillamine—Rash—Linagliptin—type 2 diabetes mellitus	0.000304	0.00142	CcSEcCtD
Penicillamine—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000304	0.00142	CcSEcCtD
Penicillamine—Skin disorder—Pioglitazone—type 2 diabetes mellitus	0.000301	0.00141	CcSEcCtD
Penicillamine—Hepatobiliary disease—Orlistat—type 2 diabetes mellitus	0.000301	0.00141	CcSEcCtD
Penicillamine—Muscular weakness—Losartan—type 2 diabetes mellitus	0.000298	0.00139	CcSEcCtD
Penicillamine—Vomiting—Acarbose—type 2 diabetes mellitus	0.000297	0.00139	CcSEcCtD
Penicillamine—Hypoglycaemia—Ramipril—type 2 diabetes mellitus	0.000297	0.00139	CcSEcCtD
Penicillamine—Thrombocytopenia—Glimepiride—type 2 diabetes mellitus	0.000295	0.00138	CcSEcCtD
Penicillamine—Rash—Acarbose—type 2 diabetes mellitus	0.000295	0.00138	CcSEcCtD
Penicillamine—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000295	0.00138	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Glipizide—type 2 diabetes mellitus	0.000294	0.00138	CcSEcCtD
Penicillamine—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.000293	0.00137	CcSEcCtD
Penicillamine—Tinnitus—Gliclazide—type 2 diabetes mellitus	0.000293	0.00137	CcSEcCtD
Penicillamine—Skin disorder—Sitagliptin—type 2 diabetes mellitus	0.000292	0.00136	CcSEcCtD
Penicillamine—Haemoglobin—Valsartan—type 2 diabetes mellitus	0.00029	0.00136	CcSEcCtD
Penicillamine—Nausea—Tolazamide—type 2 diabetes mellitus	0.000289	0.00135	CcSEcCtD
Penicillamine—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000289	0.00135	CcSEcCtD
Penicillamine—Eosinophilia—Losartan—type 2 diabetes mellitus	0.000289	0.00135	CcSEcCtD
Penicillamine—Haemorrhage—Valsartan—type 2 diabetes mellitus	0.000289	0.00135	CcSEcCtD
Penicillamine—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—AVP—type 2 diabetes mellitus	0.000288	0.0179	CbGpPWpGaD
Penicillamine—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000288	0.00135	CcSEcCtD
Penicillamine—Anorexia—Glimepiride—type 2 diabetes mellitus	0.000287	0.00134	CcSEcCtD
Penicillamine—Neuropathy peripheral—Metformin—type 2 diabetes mellitus	0.000287	0.00134	CcSEcCtD
Penicillamine—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000287	0.00134	CcSEcCtD
Penicillamine—Haemoglobin—Orlistat—type 2 diabetes mellitus	0.000287	0.00134	CcSEcCtD
Penicillamine—Pancreatitis—Losartan—type 2 diabetes mellitus	0.000286	0.00134	CcSEcCtD
Penicillamine—Haemorrhage—Orlistat—type 2 diabetes mellitus	0.000285	0.00133	CcSEcCtD
Penicillamine—Urinary tract disorder—Valsartan—type 2 diabetes mellitus	0.000285	0.00133	CcSEcCtD
Penicillamine—Rash—Nateglinide—type 2 diabetes mellitus	0.000284	0.00133	CcSEcCtD
Penicillamine—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000284	0.00133	CcSEcCtD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.000284	0.0176	CbGpPWpGaD
Penicillamine—Urethral disorder—Valsartan—type 2 diabetes mellitus	0.000283	0.00132	CcSEcCtD
Penicillamine—Anxiety—Bromocriptine—type 2 diabetes mellitus	0.000283	0.00132	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Pioglitazone—type 2 diabetes mellitus	0.000282	0.00132	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Bromocriptine—type 2 diabetes mellitus	0.000282	0.00132	CcSEcCtD
Penicillamine—Urinary tract disorder—Orlistat—type 2 diabetes mellitus	0.000282	0.00132	CcSEcCtD
Penicillamine—Anaemia—Glyburide—type 2 diabetes mellitus	0.000282	0.00132	CcSEcCtD
Penicillamine—Decreased appetite—Glipizide—type 2 diabetes mellitus	0.000281	0.00131	CcSEcCtD
Penicillamine—Urethral disorder—Orlistat—type 2 diabetes mellitus	0.00028	0.00131	CcSEcCtD
Penicillamine—Nausea—Acarbose—type 2 diabetes mellitus	0.000278	0.0013	CcSEcCtD
Penicillamine—Hepatobiliary disease—Metformin—type 2 diabetes mellitus	0.000277	0.00129	CcSEcCtD
Penicillamine—Mental disorder—Gliclazide—type 2 diabetes mellitus	0.000275	0.00129	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Sitagliptin—type 2 diabetes mellitus	0.000274	0.00128	CcSEcCtD
Penicillamine—Leukopenia—Glyburide—type 2 diabetes mellitus	0.000273	0.00127	CcSEcCtD
Penicillamine—Renal failure—Irbesartan—type 2 diabetes mellitus	0.000272	0.00127	CcSEcCtD
Penicillamine—Nausea—Nateglinide—type 2 diabetes mellitus	0.000268	0.00125	CcSEcCtD
Penicillamine—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000267	0.00125	CcSEcCtD
Penicillamine—Abdominal pain upper—Ramipril—type 2 diabetes mellitus	0.000264	0.00124	CcSEcCtD
Penicillamine—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000264	0.00124	CcSEcCtD
Penicillamine—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000262	0.00123	CcSEcCtD
Penicillamine—Angiopathy—Valsartan—type 2 diabetes mellitus	0.000262	0.00122	CcSEcCtD
Penicillamine—Hepatobiliary disease—Irbesartan—type 2 diabetes mellitus	0.000261	0.00122	CcSEcCtD
Penicillamine—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000261	0.00122	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Ramipril—type 2 diabetes mellitus	0.000261	0.00122	CcSEcCtD
Penicillamine—Arthralgia—Glyburide—type 2 diabetes mellitus	0.000259	0.00121	CcSEcCtD
Penicillamine—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.000259	0.00121	CcSEcCtD
Penicillamine—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.000258	0.00121	CcSEcCtD
Penicillamine—Urticaria—Glipizide—type 2 diabetes mellitus	0.000257	0.0012	CcSEcCtD
Penicillamine—Renal failure—Losartan—type 2 diabetes mellitus	0.000256	0.0012	CcSEcCtD
Penicillamine—Alopecia—Valsartan—type 2 diabetes mellitus	0.000255	0.00119	CcSEcCtD
Penicillamine—Neuropathy peripheral—Losartan—type 2 diabetes mellitus	0.000255	0.00119	CcSEcCtD
Penicillamine—Mental disorder—Valsartan—type 2 diabetes mellitus	0.000253	0.00118	CcSEcCtD
Penicillamine—Anaemia—Gliclazide—type 2 diabetes mellitus	0.000253	0.00118	CcSEcCtD
Penicillamine—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000253	0.00118	CcSEcCtD
Penicillamine—Alopecia—Orlistat—type 2 diabetes mellitus	0.000252	0.00118	CcSEcCtD
Penicillamine—Agitation—Gliclazide—type 2 diabetes mellitus	0.000251	0.00118	CcSEcCtD
Penicillamine—Asthma—Ramipril—type 2 diabetes mellitus	0.00025	0.00117	CcSEcCtD
Penicillamine—Mental disorder—Orlistat—type 2 diabetes mellitus	0.00025	0.00117	CcSEcCtD
Penicillamine—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000248	0.00116	CcSEcCtD
Penicillamine—Eosinophilia—Ramipril—type 2 diabetes mellitus	0.000248	0.00116	CcSEcCtD
Penicillamine—Rash—Repaglinide—type 2 diabetes mellitus	0.000246	0.00115	CcSEcCtD
Penicillamine—Dysgeusia—Valsartan—type 2 diabetes mellitus	0.000246	0.00115	CcSEcCtD
Penicillamine—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000246	0.00115	CcSEcCtD
Penicillamine—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000246	0.00115	CcSEcCtD
Penicillamine—Pancreatitis—Ramipril—type 2 diabetes mellitus	0.000245	0.00115	CcSEcCtD
Penicillamine—Urinary tract disorder—Irbesartan—type 2 diabetes mellitus	0.000245	0.00115	CcSEcCtD
Penicillamine—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000245	0.00114	CcSEcCtD
Penicillamine—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000243	0.00114	CcSEcCtD
Penicillamine—Urethral disorder—Irbesartan—type 2 diabetes mellitus	0.000243	0.00114	CcSEcCtD
Penicillamine—Dysgeusia—Orlistat—type 2 diabetes mellitus	0.000243	0.00114	CcSEcCtD
Penicillamine—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000243	0.00113	CcSEcCtD
Penicillamine—Urticaria—Glimepiride—type 2 diabetes mellitus	0.00024	0.00112	CcSEcCtD
Penicillamine—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000239	0.00112	CcSEcCtD
Penicillamine—Angiopathy—Metformin—type 2 diabetes mellitus	0.000239	0.00112	CcSEcCtD
Penicillamine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000238	0.00111	CcSEcCtD
Penicillamine—Pancytopenia—Ramipril—type 2 diabetes mellitus	0.000238	0.00111	CcSEcCtD
Penicillamine—Anorexia—Glyburide—type 2 diabetes mellitus	0.000237	0.00111	CcSEcCtD
Penicillamine—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000236	0.00111	CcSEcCtD
Penicillamine—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.000233	0.00109	CcSEcCtD
Penicillamine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000233	0.00109	CcSEcCtD
Penicillamine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000232	0.00109	CcSEcCtD
Penicillamine—Anxiety—Gliclazide—type 2 diabetes mellitus	0.000232	0.00109	CcSEcCtD
Penicillamine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000232	0.00108	CcSEcCtD
Penicillamine—Tinnitus—Irbesartan—type 2 diabetes mellitus	0.000231	0.00108	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000231	0.00108	CcSEcCtD
Penicillamine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000228	0.00107	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000227	0.00106	CcSEcCtD
Penicillamine—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000225	0.00105	CcSEcCtD
Penicillamine—Dysgeusia—Metformin—type 2 diabetes mellitus	0.000224	0.00105	CcSEcCtD
Penicillamine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000222	0.00104	CcSEcCtD
Penicillamine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000221	0.00104	CcSEcCtD
Penicillamine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000221	0.00103	CcSEcCtD
Penicillamine—Renal failure—Ramipril—type 2 diabetes mellitus	0.000219	0.00103	CcSEcCtD
Penicillamine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000219	0.00102	CcSEcCtD
Penicillamine—Neuropathy peripheral—Ramipril—type 2 diabetes mellitus	0.000219	0.00102	CcSEcCtD
Penicillamine—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000219	0.00102	CcSEcCtD
Penicillamine—Tinnitus—Losartan—type 2 diabetes mellitus	0.000218	0.00102	CcSEcCtD
Penicillamine—Stomatitis—Ramipril—type 2 diabetes mellitus	0.000217	0.00102	CcSEcCtD
Penicillamine—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000217	0.00101	CcSEcCtD
Penicillamine—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000216	0.00101	CcSEcCtD
Penicillamine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000216	0.00101	CcSEcCtD
Penicillamine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000215	0.00101	CcSEcCtD
Penicillamine—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000214	0.001	CcSEcCtD
Penicillamine—Anxiety—Valsartan—type 2 diabetes mellitus	0.000213	0.000997	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000212	0.000993	CcSEcCtD
Penicillamine—Angiopathy—Losartan—type 2 diabetes mellitus	0.000212	0.00099	CcSEcCtD
Penicillamine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000212	0.00099	CcSEcCtD
Penicillamine—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000212	0.000989	CcSEcCtD
Penicillamine—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000211	0.000986	CcSEcCtD
Penicillamine—Anxiety—Orlistat—type 2 diabetes mellitus	0.000211	0.000985	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.00021	0.000982	CcSEcCtD
Penicillamine—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000208	0.000973	CcSEcCtD
Penicillamine—Alopecia—Losartan—type 2 diabetes mellitus	0.000206	0.000965	CcSEcCtD
Penicillamine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000206	0.000964	CcSEcCtD
Penicillamine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000206	0.000961	CcSEcCtD
Penicillamine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000205	0.00096	CcSEcCtD
Penicillamine—Rash—Glipizide—type 2 diabetes mellitus	0.000204	0.000952	CcSEcCtD
Penicillamine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000204	0.000951	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000203	0.000951	CcSEcCtD
Penicillamine—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000201	0.000939	CcSEcCtD
Penicillamine—Anaemia—Irbesartan—type 2 diabetes mellitus	0.0002	0.000933	CcSEcCtD
Penicillamine—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000199	0.000931	CcSEcCtD
Penicillamine—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000199	0.000931	CcSEcCtD
Penicillamine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000198	0.000928	CcSEcCtD
Penicillamine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000198	0.000923	CcSEcCtD
Penicillamine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000197	0.00092	CcSEcCtD
Penicillamine—Anorexia—Valsartan—type 2 diabetes mellitus	0.000196	0.000914	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000194	0.000905	CcSEcCtD
Penicillamine—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000193	0.000904	CcSEcCtD
Penicillamine—Nausea—Glipizide—type 2 diabetes mellitus	0.000192	0.000897	CcSEcCtD
Penicillamine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000192	0.000896	CcSEcCtD
Penicillamine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000191	0.000893	CcSEcCtD
Penicillamine—Rash—Glimepiride—type 2 diabetes mellitus	0.00019	0.000889	CcSEcCtD
Penicillamine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00019	0.000888	CcSEcCtD
Penicillamine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000189	0.000886	CcSEcCtD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.000189	0.0118	CbGpPWpGaD
Penicillamine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000189	0.000885	CcSEcCtD
Penicillamine—Anaemia—Losartan—type 2 diabetes mellitus	0.000188	0.000878	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000187	0.000874	CcSEcCtD
Penicillamine—Agitation—Losartan—type 2 diabetes mellitus	0.000187	0.000873	CcSEcCtD
Penicillamine—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000187	0.000873	CcSEcCtD
Penicillamine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000186	0.00087	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000185	0.000863	CcSEcCtD
Penicillamine—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000184	0.00086	CcSEcCtD
Penicillamine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000183	0.000857	CcSEcCtD
Penicillamine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000183	0.000856	CcSEcCtD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.000183	0.0114	CbGpPWpGaD
Penicillamine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000183	0.000855	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000183	0.000854	CcSEcCtD
Penicillamine—SLCO1B1—Bile acid and bile salt metabolism—ALB—type 2 diabetes mellitus	0.000183	0.0113	CbGpPWpGaD
Penicillamine—Leukopenia—Losartan—type 2 diabetes mellitus	0.000182	0.000851	CcSEcCtD
Penicillamine—Skin disorder—Metformin—type 2 diabetes mellitus	0.000181	0.000848	CcSEcCtD
Penicillamine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000179	0.000837	CcSEcCtD
Penicillamine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000179	0.000835	CcSEcCtD
Penicillamine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000178	0.000834	CcSEcCtD
Penicillamine—Anorexia—Metformin—type 2 diabetes mellitus	0.000178	0.000832	CcSEcCtD
Penicillamine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000177	0.000829	CcSEcCtD
Penicillamine—Alopecia—Ramipril—type 2 diabetes mellitus	0.000177	0.000827	CcSEcCtD
Penicillamine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000176	0.000825	CcSEcCtD
Penicillamine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000176	0.000824	CcSEcCtD
Penicillamine—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000175	0.00082	CcSEcCtD
Penicillamine—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—type 2 diabetes mellitus	0.000175	0.0108	CbGpPWpGaD
Penicillamine—Arthralgia—Losartan—type 2 diabetes mellitus	0.000173	0.000809	CcSEcCtD
Penicillamine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000173	0.000808	CcSEcCtD
Penicillamine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000173	0.000807	CcSEcCtD
Penicillamine—Anxiety—Losartan—type 2 diabetes mellitus	0.000172	0.000806	CcSEcCtD
Penicillamine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000171	0.000802	CcSEcCtD
Penicillamine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000171	0.000801	CcSEcCtD
Penicillamine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000171	0.000801	CcSEcCtD
Penicillamine—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000171	0.000798	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.00017	0.000796	CcSEcCtD
Penicillamine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00017	0.000795	CcSEcCtD
Penicillamine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000168	0.000786	CcSEcCtD
Penicillamine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000164	0.000769	CcSEcCtD
Penicillamine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000163	0.000762	CcSEcCtD
Penicillamine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000162	0.000759	CcSEcCtD
Penicillamine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000162	0.000759	CcSEcCtD
Penicillamine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000162	0.000755	CcSEcCtD
Penicillamine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000161	0.000753	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000161	0.000751	CcSEcCtD
Penicillamine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.00016	0.000749	CcSEcCtD
Penicillamine—Agitation—Ramipril—type 2 diabetes mellitus	0.00016	0.000749	CcSEcCtD
Penicillamine—Anorexia—Losartan—type 2 diabetes mellitus	0.000158	0.000739	CcSEcCtD
Penicillamine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000158	0.000739	CcSEcCtD
Penicillamine—Rash—Glyburide—type 2 diabetes mellitus	0.000157	0.000733	CcSEcCtD
Penicillamine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000157	0.000732	CcSEcCtD
Penicillamine—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000156	0.000729	CcSEcCtD
Penicillamine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000153	0.000716	CcSEcCtD
Penicillamine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000153	0.000714	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000151	0.000707	CcSEcCtD
Penicillamine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000151	0.000707	CcSEcCtD
Penicillamine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000149	0.000698	CcSEcCtD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.000149	0.00926	CbGpPWpGaD
Penicillamine—Urticaria—Metformin—type 2 diabetes mellitus	0.000148	0.000694	CcSEcCtD
Penicillamine—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000148	0.000694	CcSEcCtD
Penicillamine—Anxiety—Ramipril—type 2 diabetes mellitus	0.000148	0.000691	CcSEcCtD
Penicillamine—Nausea—Glyburide—type 2 diabetes mellitus	0.000148	0.00069	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000147	0.000689	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000144	0.00895	CbGpPWpGaD
Penicillamine—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000144	0.000674	CcSEcCtD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000144	0.00891	CbGpPWpGaD
Penicillamine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000142	0.000664	CcSEcCtD
Penicillamine—Rash—Gliclazide—type 2 diabetes mellitus	0.000141	0.000658	CcSEcCtD
Penicillamine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000141	0.000658	CcSEcCtD
Penicillamine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.00014	0.000656	CcSEcCtD
Penicillamine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.00014	0.000655	CcSEcCtD
Penicillamine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000139	0.000651	CcSEcCtD
Penicillamine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000139	0.000651	CcSEcCtD
Penicillamine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000139	0.000648	CcSEcCtD
Penicillamine—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000138	0.000646	CcSEcCtD
Penicillamine—Anorexia—Ramipril—type 2 diabetes mellitus	0.000136	0.000634	CcSEcCtD
Penicillamine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000133	0.00062	CcSEcCtD
Penicillamine—Urticaria—Losartan—type 2 diabetes mellitus	0.000132	0.000616	CcSEcCtD
Penicillamine—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000131	0.000613	CcSEcCtD
Penicillamine—Vomiting—Valsartan—type 2 diabetes mellitus	0.00013	0.00061	CcSEcCtD
Penicillamine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.00013	0.000607	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.00013	0.000606	CcSEcCtD
Penicillamine—Rash—Valsartan—type 2 diabetes mellitus	0.000129	0.000605	CcSEcCtD
Penicillamine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000129	0.000604	CcSEcCtD
Penicillamine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000129	0.000603	CcSEcCtD
Penicillamine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000128	0.000598	CcSEcCtD
Penicillamine—Rash—Orlistat—type 2 diabetes mellitus	0.000128	0.000597	CcSEcCtD
Penicillamine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000128	0.000597	CcSEcCtD
Penicillamine—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000124	0.000578	CcSEcCtD
Penicillamine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000122	0.000571	CcSEcCtD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000122	0.00758	CbGpPWpGaD
Penicillamine—Nausea—Valsartan—type 2 diabetes mellitus	0.000122	0.00057	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGDS—type 2 diabetes mellitus	0.000121	0.00753	CbGpPWpGaD
Penicillamine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000121	0.000564	CcSEcCtD
Penicillamine—Nausea—Orlistat—type 2 diabetes mellitus	0.00012	0.000563	CcSEcCtD
Penicillamine—Vomiting—Metformin—type 2 diabetes mellitus	0.000119	0.000555	CcSEcCtD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000118	0.00732	CbGpPWpGaD
Penicillamine—Rash—Metformin—type 2 diabetes mellitus	0.000118	0.000551	CcSEcCtD
Penicillamine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000118	0.00055	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	0.000115	0.00714	CbGpPWpGaD
Penicillamine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000114	0.000531	CcSEcCtD
Penicillamine—Urticaria—Ramipril—type 2 diabetes mellitus	0.000113	0.000528	CcSEcCtD
Penicillamine—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000112	0.000526	CcSEcCtD
Penicillamine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000112	0.000524	CcSEcCtD
Penicillamine—Rash—Irbesartan—type 2 diabetes mellitus	0.000111	0.00052	CcSEcCtD
Penicillamine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000111	0.000519	CcSEcCtD
Penicillamine—Nausea—Metformin—type 2 diabetes mellitus	0.000111	0.000519	CcSEcCtD
Penicillamine—Vomiting—Losartan—type 2 diabetes mellitus	0.000105	0.000493	CcSEcCtD
Penicillamine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000105	0.00049	CcSEcCtD
Penicillamine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000105	0.00049	CcSEcCtD
Penicillamine—Rash—Losartan—type 2 diabetes mellitus	0.000105	0.000489	CcSEcCtD
Penicillamine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000105	0.000489	CcSEcCtD
Penicillamine—Nausea—Losartan—type 2 diabetes mellitus	9.85e-05	0.000461	CcSEcCtD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	9.81e-05	0.00609	CbGpPWpGaD
Penicillamine—Diarrhoea—Ramipril—type 2 diabetes mellitus	9.73e-05	0.000455	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	9.63e-05	0.00597	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	9.37e-05	0.00581	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	9.3e-05	0.00577	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	9.3e-05	0.00577	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	9.14e-05	0.00567	CbGpPWpGaD
Penicillamine—Vomiting—Ramipril—type 2 diabetes mellitus	9.04e-05	0.000423	CcSEcCtD
Penicillamine—Rash—Ramipril—type 2 diabetes mellitus	8.97e-05	0.000419	CcSEcCtD
Penicillamine—Dermatitis—Ramipril—type 2 diabetes mellitus	8.96e-05	0.000419	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	8.94e-05	0.00555	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	8.72e-05	0.00541	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	8.5e-05	0.00528	CbGpPWpGaD
Penicillamine—Nausea—Ramipril—type 2 diabetes mellitus	8.45e-05	0.000395	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	8.32e-05	0.00516	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	8.32e-05	0.00516	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	8.32e-05	0.00516	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	7.6e-05	0.00471	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	7.58e-05	0.0047	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	7.58e-05	0.0047	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	7.54e-05	0.00468	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	7.41e-05	0.0046	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	7.3e-05	0.00453	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	7.3e-05	0.00453	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	7.28e-05	0.00452	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	7.17e-05	0.00445	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	6.63e-05	0.00411	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	6.3e-05	0.00391	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	6.3e-05	0.00391	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	6.2e-05	0.00385	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	6.19e-05	0.00384	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—BHMT—type 2 diabetes mellitus	6.18e-05	0.00384	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	5.99e-05	0.00372	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	5.74e-05	0.00356	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PTGDS—type 2 diabetes mellitus	5.4e-05	0.00335	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—AANAT—type 2 diabetes mellitus	5.4e-05	0.00335	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	5.14e-05	0.00319	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GPD2—type 2 diabetes mellitus	5.12e-05	0.00318	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CDO1—type 2 diabetes mellitus	5.12e-05	0.00318	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	5.01e-05	0.00311	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	4.99e-05	0.00309	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	4.98e-05	0.00309	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—AK1—type 2 diabetes mellitus	4.89e-05	0.00303	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	4.83e-05	0.003	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	4.76e-05	0.00295	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	4.76e-05	0.00295	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	4.65e-05	0.00288	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	4.62e-05	0.00287	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	4.59e-05	0.00285	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SLC5A4—type 2 diabetes mellitus	4.51e-05	0.0028	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—MAT1A—type 2 diabetes mellitus	4.51e-05	0.0028	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	4.49e-05	0.00279	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	4.41e-05	0.00273	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	4.37e-05	0.00271	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PPP1R3C—type 2 diabetes mellitus	4.36e-05	0.0027	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ND1—type 2 diabetes mellitus	4.36e-05	0.0027	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ENPP1—type 2 diabetes mellitus	4.36e-05	0.0027	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—G6PC—type 2 diabetes mellitus	4.36e-05	0.0027	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—HBA2—type 2 diabetes mellitus	4.36e-05	0.0027	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GCGR—type 2 diabetes mellitus	4.22e-05	0.00262	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	4.06e-05	0.00252	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	4.05e-05	0.00251	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CYTB—type 2 diabetes mellitus	3.98e-05	0.00247	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—OXCT1—type 2 diabetes mellitus	3.98e-05	0.00247	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SRD5A1—type 2 diabetes mellitus	3.88e-05	0.00241	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	3.86e-05	0.0024	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	3.75e-05	0.00233	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ACACA—type 2 diabetes mellitus	3.7e-05	0.0023	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—HSD17B3—type 2 diabetes mellitus	3.7e-05	0.0023	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—STAR—type 2 diabetes mellitus	3.7e-05	0.0023	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	3.7e-05	0.0023	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ABCC8—type 2 diabetes mellitus	3.55e-05	0.0022	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CBS—type 2 diabetes mellitus	3.55e-05	0.0022	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—COX2—type 2 diabetes mellitus	3.42e-05	0.00212	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SLC5A2—type 2 diabetes mellitus	3.42e-05	0.00212	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—NCOA6—type 2 diabetes mellitus	3.36e-05	0.00208	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	3.36e-05	0.00208	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—UCP3—type 2 diabetes mellitus	3.3e-05	0.00205	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—UCP2—type 2 diabetes mellitus	3.3e-05	0.00205	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—HSD11B1—type 2 diabetes mellitus	3.3e-05	0.00205	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	3.2e-05	0.00199	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.19e-05	0.00198	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.18e-05	0.00197	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.15e-05	0.00195	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PCK1—type 2 diabetes mellitus	3.1e-05	0.00193	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	3.05e-05	0.0019	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.04e-05	0.00189	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	2.98e-05	0.00185	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—HK1—type 2 diabetes mellitus	2.91e-05	0.0018	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	2.9e-05	0.0018	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.84e-05	0.00176	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—LPA—type 2 diabetes mellitus	2.81e-05	0.00174	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GCKR—type 2 diabetes mellitus	2.81e-05	0.00174	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—KCNJ11—type 2 diabetes mellitus	2.81e-05	0.00174	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—HSD3B2—type 2 diabetes mellitus	2.81e-05	0.00174	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	2.7e-05	0.00167	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ALDOB—type 2 diabetes mellitus	2.69e-05	0.00167	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2.61e-05	0.00162	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.57e-05	0.00159	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.56e-05	0.00159	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	2.53e-05	0.00157	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GLP1R—type 2 diabetes mellitus	2.5e-05	0.00155	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.41e-05	0.00149	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SLC2A2—type 2 diabetes mellitus	2.34e-05	0.00145	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CPT1A—type 2 diabetes mellitus	2.29e-05	0.00142	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—MTR—type 2 diabetes mellitus	2.29e-05	0.00142	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—NAMPT—type 2 diabetes mellitus	2.24e-05	0.00139	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	2.23e-05	0.00138	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—HBA1—type 2 diabetes mellitus	2.23e-05	0.00138	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—LIPC—type 2 diabetes mellitus	2.23e-05	0.00138	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GCK—type 2 diabetes mellitus	2.23e-05	0.00138	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CYP11A1—type 2 diabetes mellitus	2.22e-05	0.00137	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SLC9A1—type 2 diabetes mellitus	2.18e-05	0.00135	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CETP—type 2 diabetes mellitus	2.15e-05	0.00133	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.01e-05	0.00124	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PSMD6—type 2 diabetes mellitus	2e-05	0.00124	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SREBF1—type 2 diabetes mellitus	2e-05	0.00124	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SNAP25—type 2 diabetes mellitus	2e-05	0.00124	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CTGF—type 2 diabetes mellitus	1.96e-05	0.00122	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—HMGCR—type 2 diabetes mellitus	1.95e-05	0.00121	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.92e-05	0.00119	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.91e-05	0.00118	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.9e-05	0.00118	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.83e-05	0.00113	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.81e-05	0.00112	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.81e-05	0.00112	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.76e-05	0.00109	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.75e-05	0.00109	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.73e-05	0.00108	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GCG—type 2 diabetes mellitus	1.73e-05	0.00108	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.49e-05	0.000927	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GNB3—type 2 diabetes mellitus	1.49e-05	0.000927	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—HMOX1—type 2 diabetes mellitus	1.49e-05	0.000923	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CAT—type 2 diabetes mellitus	1.47e-05	0.000911	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—APOB—type 2 diabetes mellitus	1.42e-05	0.000884	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GSTM1—type 2 diabetes mellitus	1.39e-05	0.00086	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—LPL—type 2 diabetes mellitus	1.36e-05	0.000844	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ADCY5—type 2 diabetes mellitus	1.33e-05	0.000826	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GPX1—type 2 diabetes mellitus	1.33e-05	0.000824	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CD36—type 2 diabetes mellitus	1.29e-05	0.000802	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.28e-05	0.000792	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—MTHFR—type 2 diabetes mellitus	1.22e-05	0.00076	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PPARA—type 2 diabetes mellitus	1.2e-05	0.000746	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—AGT—type 2 diabetes mellitus	1.16e-05	0.000722	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CALM1—type 2 diabetes mellitus	1.14e-05	0.00071	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—APOE—type 2 diabetes mellitus	1.14e-05	0.000708	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—APOA1—type 2 diabetes mellitus	1.13e-05	0.000699	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PPARG—type 2 diabetes mellitus	9.93e-06	0.000616	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—INS—type 2 diabetes mellitus	9.74e-06	0.000604	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ALB—type 2 diabetes mellitus	8.93e-06	0.000554	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—NOS3—type 2 diabetes mellitus	8.54e-06	0.00053	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PIK3R1—type 2 diabetes mellitus	8.54e-06	0.00053	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PTGS2—type 2 diabetes mellitus	7.81e-06	0.000485	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—AKT1—type 2 diabetes mellitus	3.93e-06	0.000244	CbGpPWpGaD
